PBS listing for ‘Australian success story’ blood cancer drug

1 July 2022 - A pill that removes the need for chemotherapy for some cancer sufferers has been put on ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2022

1 July 2022 - The July 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 June 2022

1 June 2022 - The June 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

First million dollar medicine listed on the PBS

4 May 2022 - Zolgensma has the great honour of being the first medicine listed on the PBS with a ...

Read more →

COVID-19 oral treatment listed on PBS from 1 May 2022

1 May 2022 - This prescription only oral treatment has been found to be effective in treating mild to moderate ...

Read more →

Schedule of Pharmaceutical Benefits - 1 May 2022

1 May 2022 - The May 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Pharmaceutical Benefits Scheme listings to save patients millions

1 May 2022 - Health Minister Greg Hunt has announced a series of new Pharmaceutical Benefits Scheme listings which will save ...

Read more →

PBS listing of Paxlovid (nirmatrelvir and ritonavir)

 9 April 2022 - Commencing 1 May 2022, Paxlovid (nirmatrelvir and ritonavir) will be listed on the PBS as a General ...

Read more →

Schedule of Pharmaceutical Benefits - 1 April 2022

1 April 2022 - The April 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Landmark PBS listing for Australians with cystic fibrosis

27 March 2022 - From April 1 2022, Trikafta (elexacaftor with tezacaftor and ivacaftor and ivacaftor) will be available on ...

Read more →

Expanded PBS listing for lung disease medication

25 March 2022 - The Australian Government is helping more Australians access the medications they need with a new addition to ...

Read more →

BeiGene hits major milestone with first PBS approved cancer treatment

1 March 2022 - BeiGene is welcoming the listing of Brukinsa (zanubrutinib), a targeted treatment for mantle cell lymphoma, an aggressive ...

Read more →

New PBS listings from 1 March 2022

1 March 2022 - Australians will have access to four new medicines through the Pharmaceutical Benefits Scheme from March 1 to ...

Read more →

Lagevrio (molnupiravir) PBS listing

1 March 2022 - Commencing 1 March 2022, Lagevrio (molnupiravir) will be listed on the PBS Section 85 program as an ...

Read more →

Schedule of Pharmaceutical Benefits - 1 March 2022

1 March 2022 - The March 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →